<--- Back to Details
| First Page | Document Content | |
|---|---|---|
 Date: 2015-11-13 16:30:47Chemistry Drug discovery Medical research Computational chemistry Cheminformatics Medicinal chemistry Quantitative structureactivity relationship Mutation Nature Mutagen In silico |
Add to Reading List |
In silico mutagenicity assessment methodologies relating to E&L strategies Glenn J. Myatt () Leadscope, Inc.![SL-35: Oncology Phenotypic Screening. Macrocycles. Phenotypic screening is a firmly established technology that has contributed to the identification of valuable therapeutic agents in oncology drug discovery [1]. For exa](https://www.pdfsearch.io/img/4b02d42f9851bfe75651c493e50c552b.jpg "SL-35: Oncology Phenotypic Screening. Macrocycles. Phenotypic screening is a firmly established technology that has contributed to the identification of valuable therapeutic agents in oncology drug discovery [1]. For exa")
